Literature DB >> 21081571

Screening for atherosclerotic plaques in the abdominal aorta in high-risk patients with multicontrast-weighted MRI: a prospective study at 3.0 and 1.5 tesla.

J-H Buhk1, A-K Finck-Wedel, R Buchert, P Bannas, B Schnackenburg, F U Beil, G Adam, C Weber.   

Abstract

OBJECTIVE: This prospective study compares MRI of atherosclerotic plaque in the abdominal aorta at 3 T with that at 1.5 T in patients suffering from hereditary hyperlipidaemia, a major risk factor for atherosclerosis.
METHODS: MRI of the abdominal aorta at 1.5 and 3 T was performed in 21 patients (mean age 58 years). The study protocol consisted of proton density (PD), T(1), T(2) and fat-saturated T(2) weighted black blood images of the abdominal aorta in corresponding orientation. Two independent radiologists performed image rating. First, image quality was rated on a five-point scale. Second, atherosclerotic plaques were scored according to the modified American Heart Association (AHA) classification and analysed for field strength-related differences. Weighted κ statistics were calculated to assess interobserver agreement.
RESULTS: Interobserver agreement was substantial for nearly all categories. MRI at 3 T offered superior image quality in all contrast weightings, most significantly in T(1) and T(2) weighted techniques. Plaque burden in the study collective was unexpectedly moderate. The majority of plaques were classified as AHA III lesions; no lesions were classified above AHA V. There was no significant influence of the field strength regarding the AHA classification.
CONCLUSION: Abdominal aortal plaque screening is basically feasible at both field strengths, whereas the image quality is rated superior at 3 T. However, the role of the method in clinical practice remains uncertain, since substantial findings in the high-risk collective were scarce.

Entities:  

Mesh:

Year:  2010        PMID: 21081571      PMCID: PMC3473760          DOI: 10.1259/bjr/16555263

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  29 in total

1.  In vivo identification of complicated upper thoracic aorta and arch vessel plaque by MR direct thrombus imaging in patients investigated for cerebrovascular disease.

Authors:  Richard Bitar; Alan R Moody; General Leung; Alexander Kiss; David Gladstone; Demetrios J Sahlas; Robert Maggisano
Journal:  AJR Am J Roentgenol       Date:  2006-07       Impact factor: 3.959

Review 2.  The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment.

Authors:  Tobias Saam; Thomas S Hatsukami; Norihide Takaya; Baocheng Chu; Hunter Underhill; William S Kerwin; Jianming Cai; Marina S Ferguson; Chun Yuan
Journal:  Radiology       Date:  2007-07       Impact factor: 11.105

3.  Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.

Authors:  Atsushi Yonemura; Yukihiko Momiyama; Zahi A Fayad; Makoto Ayaori; Reiko Ohmori; Teruyoshi Kihara; Nobukiyo Tanaka; Kazuhiro Nakaya; Masatsune Ogura; Hiroaki Taniguchi; Masatoshi Kusuhara; Masayoshi Nagata; Haruo Nakamura; Seiichi Tamai; Fumitaka Ohsuzu
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-04

4.  Quantitative 3T MR imaging of the descending thoracic aorta: patients with familial hypercholesterolemia have an increased aortic plaque burden despite long-term lipid-lowering therapy.

Authors:  Stephan A Schmitz; Declan P O'Regan; Julie Fitzpatrick; Clare Neuwirth; Elizabeth Potter; Isabella Tosi; Joseph V Hajnal; Rossi P Naoumova
Journal:  J Vasc Interv Radiol       Date:  2008-08-09       Impact factor: 3.464

5.  Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1968-10       Impact factor: 17.737

Review 6.  Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment.

Authors:  Marc Sirol; Valentin Fuster; Zahi A Fayad
Journal:  Curr Mol Med       Date:  2006-08       Impact factor: 2.222

7.  The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization.

Authors:  M Shinnar; J T Fallon; S Wehrli; M Levin; D Dalmacy; Z A Fayad; J J Badimon; M Harrington; E Harrington; V Fuster
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

8.  Assessment and reproducibility of aortic atherosclerosis magnetic resonance imaging: impact of 3-Tesla field strength and parallel imaging.

Authors:  Christopher D Maroules; Roderick McColl; Amit Khera; Ronald M Peshock
Journal:  Invest Radiol       Date:  2008-09       Impact factor: 6.016

Review 9.  Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.

Authors:  Karen C Briley-Saebo; Willem J M Mulder; Venkatesh Mani; Fabien Hyafil; Vardan Amirbekian; Juan Gilberto S Aguinaldo; Edward A Fisher; Zahi A Fayad
Journal:  J Magn Reson Imaging       Date:  2007-09       Impact factor: 4.813

10.  Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

Authors:  Carmen Burtea; Sophie Laurent; Oltea Murariu; Dirk Rattat; Gérard Toubeau; Alfons Verbruggen; David Vansthertem; Luce Vander Elst; Robert N Muller
Journal:  Cardiovasc Res       Date:  2008-01-03       Impact factor: 10.787

View more
  1 in total

Review 1.  Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions.

Authors:  Jerome L Fleg; Gregg W Stone; Zahi A Fayad; Juan F Granada; Thomas S Hatsukami; Frank D Kolodgie; Jacques Ohayon; Roderic Pettigrew; Marc S Sabatine; Guillermo J Tearney; Sergio Waxman; Michael J Domanski; Pothur R Srinivas; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2012-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.